Profiling Children and Youth With Cerebral Palsy in Relation to Feeding and Nutrition (Purple-N)

November 15, 2018 updated by: Nutricia Research

A Multi-country, Multi-centre, Observational, Cross-sectional Study to Evaluate Individualized Treatment and Management in Children and Adolescents With Cerebral Palsy

HCPs will complete questionnaires about their patients with Cerebral Palsy (CP) and invite parents/caregivers of these patients to fill in questionnaires as well. Questionnaires include questions on individualized treatment, nutritional profile and management, and patient characteristics.

Study Overview

Status

Completed

Conditions

Detailed Description

Coordinating health care professionals (HCPs; e.g. paediatric neurologists, physiotherapists) in different centres across different countries will be asked to participate in this cross-sectional study.

A) for the HCP to fill out a questionnaire about their CP child, related to general subject characteristics, motor function, co-morbidities, type of therapies, anthropometry, feeding mode and nutritional status; and B) for parents (/legal representatives) to receive and fill out questionnaires about their CP child and themselves, related to general subject characteristics, motor function, co-morbidities, type of therapies, anthropometry, feeding mode and nutritional status, participation and (their own) quality of life.

If parents (/legal representatives) agree to "A)", but not "B)" then a subject will still enter the study, but without the parental assessment.

Study Type

Observational

Enrollment (Actual)

499

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Praha, Czechia
        • Fakultni nemocnice v Motole
      • Athens, Greece
        • Attikon University General Hospital
      • Budapest, Hungary
        • Bethesda Children Hospital Budapest
      • Bologna, Italy
        • AO Sant'Orsola - Malpighi, Policlinico
      • Brescia, Italy
        • ASST degli Spedali Civili di Brescia
      • Milano, Italy
        • Fondazione IRCCS Istituto Neurologico "Carlo Besta"
      • Modena, Italy
        • AOU di Modena - Policlinico
      • Enschede, Netherlands
        • Roessingh centrum voor Revalidatie
      • Gdańsk, Poland
        • Medical university hospital of Gdansk
      • Poznań, Poland
        • Szpital Kliniczny im. Heliodora Swiecickiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu
      • Trnava, Slovakia
        • Fakultna nemocnica Trnava
      • Ankara, Turkey
        • Ankara University School of Medicine/Neurology
      • Ankara, Turkey
        • Gazi University School of Medicine/Neurology
      • Ankara, Turkey
        • Hacettepe University School of Medicine/Neurology
      • Ege, Turkey
        • Ege University School of Medicine/Neurology
      • Eskişehir, Turkey
        • Eskisehir Osmangazi University School of Medicine/Neurology
      • Marmara, Turkey
        • Marmara University School of Medicine/Neurology
      • Mersin, Turkey
        • Mersin University School of Medicine/Neurology
      • İnönü, Turkey
        • Inonu University School of Medicine/Neurology
      • İzmir, Turkey
        • Dokuz Eylul University School of Medicine/Neurology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 17 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Subjects between 1 month and 18 years of age with Cerebral Palsy

Description

Inclusion Criteria:

  1. Confirmed diagnosis of Cerebral Palsy
  2. Age<18 years
  3. Have visited the HCP within the last year
  4. Written informed consent provided by parents/legal representatives according to local law

Exclusion Criteria:

  1. Neurodegenerative diseases
  2. Acute infections: meningitis, encephalitis or poliomyelitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Children and youth with cerebral palsy
Subjects between 1 month and 18 years of age with Cerebral Palsy who visited the coordinating HCP within the past 12 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quantify current CP characteristics 1 (general subject characteristics):
Time Frame: Data collected retrospectively, from within 12 months of entering the questionnaire

Using questionnaires to quantify current CP characteristics with respect to:

- General subject characteristics (e.g. Sex, Birth weight [g], Type of CP motor disorder [category]

Data collected retrospectively, from within 12 months of entering the questionnaire
Quantify current CP characteristics 2 (anthropometry):
Time Frame: Data collected retrospectively, from within 12 months of entering the questionnaire

Using questionnaires to quantify current CP characteristics with respect to:

Anthropometry: length [cm]; weight [grams] and BMI (kg/m2)

Data collected retrospectively, from within 12 months of entering the questionnaire
Quantify current CP characteristics 3 (motor function)
Time Frame: Data collected retrospectively, from within 12 months of entering the questionnaire

Using questionnaires to quantify current CP characteristics with respect to:

Motor function (GMFCS [category]; GMFM measurement type [GMFM-86/GMFM-88]

Data collected retrospectively, from within 12 months of entering the questionnaire
Quantify current CP characteristics 4 (comorbidities)
Time Frame: Data collected retrospectively, from within 12 months of entering the questionnaire

Using questionnaires to quantify current CP characteristics with respect to:

Comorbidities: epilepsy, cognitive function, GI problems [categories]

Data collected retrospectively, from within 12 months of entering the questionnaire
Quantify current CP characteristics 5 (therapies)
Time Frame: Data collected retrospectively, from within 12 months of entering the questionnaire

Using questionnaires to quantify current CP characteristics with respect to:

Type and frequency of physical/occupational therapy [type, number of hours per day /days per week]

Data collected retrospectively, from within 12 months of entering the questionnaire
Quantify current CP characteristics 6 (feeding mode)
Time Frame: Data collected retrospectively, from within 12 months of entering the questionnaire

Using questionnaires to quantify current CP characteristics with respect to:

Feeding mode and/or problems (tube feeding [yes/no], type of tube feeding etc)

Data collected retrospectively, from within 12 months of entering the questionnaire
Quantify current CP characteristics 7 (nutritional status)
Time Frame: Data collected retrospectively, from within 12 months of entering the questionnaire

Using questionnaires to quantify current CP characteristics with respect to:

Nutritional status (HCP and parent perspective on nutritional status, concerns [yes/no])

Data collected retrospectively, from within 12 months of entering the questionnaire

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life and participation 1
Time Frame: Data collected retrospectively, from within 12 months of entering the questionnaire
Questionnaire to assess Quality of Life of subjects with CP [scores on domains]
Data collected retrospectively, from within 12 months of entering the questionnaire
Quality of life and participation 2
Time Frame: Data collected retrospectively, from within 12 months of entering the questionnaire
Questionnaire to assess Quality of Life of parents (/legal representatives) of subjects with CP [scores on domains]
Data collected retrospectively, from within 12 months of entering the questionnaire
Quality of life and participation 3
Time Frame: Data collected retrospectively, from within 12 months of entering the questionnaire
Level of participation included in the general parent questionnaire [categories]
Data collected retrospectively, from within 12 months of entering the questionnaire

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 11, 2017

Primary Completion (ACTUAL)

July 3, 2018

Study Completion (ACTUAL)

July 3, 2018

Study Registration Dates

First Submitted

March 21, 2018

First Submitted That Met QC Criteria

April 13, 2018

First Posted (ACTUAL)

April 17, 2018

Study Record Updates

Last Update Posted (ACTUAL)

November 16, 2018

Last Update Submitted That Met QC Criteria

November 15, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

3
Subscribe